Interview by Sree Roy In 2015, the ResMed-funded SERVE-HF trial resulted in practice-changing guidance due to its shocking finding that a minute ventilation-triggered adaptive servo-ventilation (ASV) device increased the risk of mortality in people with central sleep apnea and … [Read more...]